Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing since 12/18/2024, newest first.
| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Voyager Therapeutics, Inc.
13G/A
Amendment 3
VYGR · 92915B106
|
9.9% |
2/14/2025
Event 12/31/2024
|
|||
| Armistice Capital, LLC | 9.9% | ||||
| Steven Boyd | 9.9% | ||||
|
Catheter Precision, Inc.
13G/A
Amendment 2
VTAK · 74933X609
|
10.0% |
2/14/2025
Event 12/31/2024
|
|||
| Armistice Capital, LLC | 10.0% | ||||
| Steven Boyd | 10.0% | ||||
|
Volitionrx Ltd
13G/A
Amendment 1
VNRX · 928661107
|
10.0% |
2/14/2025
Event 12/31/2024
|
|||
| Armistice Capital, LLC | 10.0% | ||||
| Steven Boyd | 10.0% | ||||
|
Vincerx Pharma, Inc.
13G/A
Amendment 1
VINC · 92731L304
|
10.0% |
2/14/2025
Event 12/31/2024
|
|||
| Armistice Capital, LLC | 10.0% | ||||
| Steven Boyd | 10.0% | ||||
|
Travere Therapeutics, Inc.
13G/A
Amendment 4
TVTX · 89422G107
|
9.6% |
2/14/2025
Event 12/31/2024
|
|||
| Armistice Capital, LLC | 9.6% | ||||
| Steven Boyd | 9.6% | ||||
|
Treace Medical Concepts, Inc.
13G/A
Amendment 1
TMCI · 89455T109
|
10.0% |
2/14/2025
Event 12/31/2024
|
|||
| Armistice Capital, LLC | 10.0% | ||||
| Steven Boyd | 10.0% | ||||
|
60 Degrees Pharmaceuticals, Inc.
13G/A
Amendment 1
SXTP · 83006G203
|
10.0% |
2/14/2025
Event 12/31/2024
|
|||
| Armistice Capital, LLC | 10.0% | ||||
| Steven Boyd | 10.0% | ||||
|
Supernus Pharmaceuticals, Inc.
13G/A
Amendment 6
SUPN · 868459108
|
8.8% |
2/14/2025
Event 12/31/2024
|
|||
| Armistice Capital, LLC | 8.8% | ||||
| Steven Boyd | 8.8% | ||||
|
Steakholder Foods Ltd.
13G/A
Amendment 1
STKH · 583435201
|
10.0% |
2/14/2025
Event 12/31/2024
|
|||
| Armistice Capital, LLC | 10.0% | ||||
| Steven Boyd | 10.0% | ||||
|
Sadot Group Inc.
13G/A
Amendment 4
SDOT · 627333305
|
6.6% |
2/14/2025
Event 12/31/2024
|
|||
| Armistice Capital, LLC | 6.6% | ||||
| Steven Boyd | 6.6% | ||||
|
Rockwell Medical, Inc.
13G/A
Amendment 3
RMTI · 774374300
|
10.0% |
2/14/2025
Event 12/31/2024
|
|||
| Armistice Capital, LLC | 10.0% | ||||
| Steven Boyd | 10.0% | ||||
|
Rigel Pharmaceuticals, Inc.
13G/A
Amendment 3
RIGL · 766559702
|
6.5% |
2/14/2025
Event 12/31/2024
|
|||
| Armistice Capital, LLC | 6.5% | ||||
| Steven Boyd | 6.5% | ||||
|
PTC Therapeutics, Inc.
13G/A
Amendment 2
PTCT · 69366J200
|
8.3% |
2/14/2025
Event 12/31/2024
|
|||
| Armistice Capital, LLC | 8.3% | ||||
| Steven Boyd | 8.3% | ||||
|
Promis Neurosciences Inc.
13G/A
Amendment 1
PMN · 74346M406
|
7.7% |
2/14/2025
Event 12/31/2024
|
|||
| Armistice Capital, LLC | 7.7% | ||||
| Steven Boyd | 7.7% | ||||
|
Palisade Bio, Inc.
13G/A
Amendment 1
PALI · 696389402
|
10.0% |
2/14/2025
Event 12/31/2024
|
|||
| Armistice Capital, LLC | 10.0% | ||||
| Steven Boyd | 10.0% | ||||
|
Organovo Holdings, Inc.
13G/A
Amendment 1
ONVO · 68620A203
|
10.0% |
2/14/2025
Event 12/31/2024
|
|||
| Armistice Capital, LLC | 10.0% | ||||
| Steven Boyd | 10.0% | ||||
|
Orthofix Medical Inc.
13G/A
Amendment 2
OFIX · 68752M108
|
7.9% |
2/14/2025
Event 12/31/2024
|
|||
| Armistice Capital, LLC | 7.9% | ||||
| Steven Boyd | 7.9% | ||||
|
Nevro Corp
13G/A
Amendment 2
NVRO · 64157F103
|
10.0% |
2/14/2025
Event 12/31/2024
|
|||
| Armistice Capital, LLC | 10.0% | ||||
| Steven Boyd | 10.0% | ||||
|
NanoVibronix, Inc.
13G/A
Amendment 2
NAOV · 63008J603
|
10.0% |
2/14/2025
Event 12/31/2024
|
|||
| Armistice Capital, LLC | 10.0% | ||||
| Steven Boyd | 10.0% | ||||
|
Mural Oncology plc
13G/A
Amendment 2
MURA · G63365103
|
10.0% |
2/14/2025
Event 12/31/2024
|
|||
| Armistice Capital, LLC | 10.0% | ||||
| Steven Boyd | 10.0% | ||||
|
Aspira Women's Health Inc.
13G/A
Amendment 1
AWHL · 04537Y208
|
4.99% |
2/14/2025
Event 12/31/2024
|
|||
| Armistice Capital, LLC | 4.99% | ||||
| Steven Boyd | 4.99% | ||||
|
Presidio Property Trust, Inc.
13G/A
Amendment 4
SQFT · 74102L303
|
4.99% |
2/14/2025
Event 12/31/2024
|
|||
| Armistice Capital, LLC | 4.99% | ||||
| Steven Boyd | 4.99% | ||||
|
Rekor Systems, Inc.
13G/A
Amendment 2
REKR · 759419104
|
3.0% |
2/14/2025
Event 12/31/2024
|
|||
| Armistice Capital, LLC | 3.0% | ||||
| Steven Boyd | 3.0% | ||||
|
Avinger, Inc.
13G/A
Amendment 1
AVGR · 053734877
|
4.99% |
2/14/2025
Event 12/31/2024
|
|||
| Armistice Capital, LLC | 4.99% | ||||
| Steven Boyd | 4.99% | ||||
|
Protagenic Therapeutics, Inc.
13G/A
Amendment 4
PTIX · 74365N202
|
3.4% |
2/14/2025
Event 12/31/2024
|
|||
| Armistice Capital, LLC | 3.4% | ||||
| Steven Boyd | 3.4% | ||||
|
Neuphoria Therapeutics Inc.
13G/A
Amendment 1
NEUP · 64136E102
|
4.99% |
2/14/2025
Event 12/31/2024
|
|||
| Armistice Capital, LLC | 4.99% | ||||
| Steven Boyd | 4.99% | ||||
|
Aurinia Pharmaceuticals Inc.
13G/A
Amendment 2
AUPH · 05156V102
|
4.5% |
2/14/2025
Event 12/31/2024
|
|||
| Armistice Capital, LLC | 4.5% | ||||
| Steven Boyd | 4.5% | ||||
|
XORTX Therapeutics Inc.
13G
XRTX · 98420Q306
|
10.0% |
2/14/2025
Event 12/31/2024
|
|||
| Armistice Capital, LLC | 10.0% | ||||
| Steven Boyd | 10.0% | ||||
|
Wearable Devices Ltd.
13G
WLDS · M97838128
|
10.0% |
2/14/2025
Event 12/31/2024
|
|||
| Armistice Capital, LLC | 10.0% | ||||
| Steven Boyd | 10.0% | ||||
|
Verrica Pharmaceuticals Inc.
13G
VRCA · 92511W108
|
10.0% |
2/14/2025
Event 12/31/2024
|
|||
| Armistice Capital, LLC | 10.0% | ||||
| Steven Boyd | 10.0% | ||||
|
Avenue Therapeutics, Inc.
13G/A
Amendment 1
ATXI · 05360L403
|
4.99% |
2/14/2025
Event 12/31/2024
|
|||
| Armistice Capital, LLC | 4.99% | ||||
| Steven Boyd | 4.99% | ||||
|
Assembly Biosciences, Inc.
13G/A
Amendment 1
ASMB · 045396207
|
4.99% |
2/14/2025
Event 12/31/2024
|
|||
| Armistice Capital, LLC | 4.99% | ||||
| Steven Boyd | 4.99% | ||||
|
Aptose Biosciences Inc.
13G/A
Amendment 1
APTO · 03835T309
|
4.99% |
2/14/2025
Event 12/31/2024
|
|||
| Armistice Capital, LLC | 4.99% | ||||
| Steven Boyd | 4.99% | ||||
|
Kartoon Studios, Inc.
13G
TOON · 37229T509
|
10.0% |
2/14/2025
Event 12/31/2024
|
|||
| Armistice Capital, LLC | 10.0% | ||||
| Steven Boyd | 10.0% | ||||
|
Senti Biosciences, Inc.
13G
SNTI · 81726A209
|
10.0% |
2/14/2025
Event 12/31/2024
|
|||
| Armistice Capital, LLC | 10.0% | ||||
| Steven Boyd | 10.0% | ||||
|
Aligos Therapeutics, Inc.
13G/A
Amendment 2
ALGS · 01626L204
|
4.99% |
2/14/2025
Event 12/31/2024
|
|||
| Armistice Capital, LLC | 4.99% | ||||
| Steven Boyd | 4.99% | ||||
|
Stryve Foods, Inc.
13G
SNAX · 863685202
|
10.0% |
2/14/2025
Event 12/31/2024
|
|||
| Armistice Capital, LLC | 10.0% | ||||
| Steven Boyd | 10.0% | ||||
|
AIM ImmunoTech Inc.
13G/A
Amendment 1
AIMI · 00901B105
|
4.99% |
2/14/2025
Event 12/31/2024
|
|||
| Armistice Capital, LLC | 4.99% | ||||
| Steven Boyd | 4.99% | ||||
|
Shuttle Pharmaceuticals Holdings, Inc.
13G
SHPH · 825693302
|
7.5% |
2/14/2025
Event 12/31/2024
|
|||
| Armistice Capital, LLC | 7.5% | ||||
| Steven Boyd | 7.5% | ||||
|
Quoin Pharmaceuticals, Ltd.
13G
QNRX · 74907L300
|
10.0% |
2/14/2025
Event 12/31/2024
|
|||
| Armistice Capital, LLC | 10.0% | ||||
| Steven Boyd | 10.0% | ||||
|
Accelerate Diagnostics, Inc
13G/A
Amendment 1
AXDXQ · 00430H201
|
8.3% |
2/14/2025
Event 12/31/2024
|
|||
| Armistice Capital, LLC | 8.3% | ||||
| Steven Boyd | 8.3% | ||||
|
Palatin Technologies Inc
13G
PTNT · 696077502
|
8.5% |
2/14/2025
Event 12/31/2024
|
|||
| Armistice Capital, LLC | 8.5% | ||||
| Steven Boyd | 8.5% | ||||
|
Aridis Pharmaceuticals, Inc.
13G/A
Amendment 3
ARDS · 040334104
|
11.4% |
2/14/2025
Event 12/31/2024
|
|||
| Armistice Capital, LLC | 11.4% | ||||
| Steven Boyd | 11.4% | ||||
|
Mainz Biomed N.V.
13G
QUCY · N5436L119
|
10.0% |
2/14/2025
Event 12/31/2024
|
|||
| Armistice Capital, LLC | 10.0% | ||||
| Steven Boyd | 10.0% | ||||
|
MetaVia Inc.
13G
MTVA · 64132R404
|
10.0% |
2/14/2025
Event 12/31/2024
|
|||
| Armistice Capital, LLC | 10.0% | ||||
| Steven Boyd | 10.0% | ||||
|
Worksport Ltd
13G/A
Amendment 2
WKSP · 98139Q209
|
4.99% |
2/14/2025
Event 12/31/2024
|
|||
| Armistice Capital, LLC | 4.99% | ||||
| Steven Boyd | 4.99% | ||||
|
Windtree Therapeutics, Inc.
13G/A
Amendment 1
WINT · 97382D501
|
2.6% |
2/14/2025
Event 12/31/2024
|
|||
| Armistice Capital, LLC | 2.6% | ||||
| Steven Boyd | 2.6% | ||||
|
Vaccinex, Inc.
13G/A
Amendment 1
VCNX · 918640301
|
4.99% |
2/14/2025
Event 12/31/2024
|
|||
| Armistice Capital, LLC | 4.99% | ||||
| Steven Boyd | 4.99% | ||||
|
Allurion Technologies, Inc.
13G/A
Amendment 2
ALUR · 02008G201
|
4.99% |
2/7/2025
Event 1/31/2025
|
|||
| Armistice Capital, LLC | 4.99% | ||||
| Boyd Steven | 4.99% | ||||